Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 31
Filtrar
Mais filtros

Medicinas Complementares
Base de dados
País/Região como assunto
Tipo de documento
Intervalo de ano de publicação
1.
J Anim Sci ; 98(7)2020 Jul 01.
Artigo em Inglês | MEDLINE | ID: mdl-32619217

RESUMO

A total of 140 weanling pigs (241 × 600, DNA, Columbus, NE; initially 5.5 ± 0.79 kg body weight) were used in a 32-d study evaluating the effects of increasing dietary Fe from either iron sulfate (FeSO4) or iron carbonate (FeCO3) on nursery pig growth performance and blood Fe status. The pigs used for this trial did not receive an Fe injection after birth in order to increase the sensitivity to added dietary Fe after weaning. Pigs were weaned at approximately 21 d and allotted to pens based on the initial weight in a completely randomized block design with five pigs in each pen and four pens per treatment. Experimental treatments were arranged as a 2 × 3 + 1 factorial with main effects of dietary Fe source (FeSO4 vs. FeCO3) and level (10, 30, or 50 mg/kg of added Fe) plus a negative control with no additional dietary Fe. The basal diet contained 40 mg/kg total dietary Fe based on ingredient contributions and was formulated with an Fe-free trace mineral premix. Experimental diets were formulated below the pigs recommended Fe requirement based on NRC (2012) estimates. Experimental diets were fed in pellet form in a single phase for the duration of the trial. From day 0 to 32, there was no evidence for source × level interactions for growth performance, hemoglobin (Hb), or hematocrit (Hct) values. There was no evidence for a difference (P > 0.10) in dietary Fe source. Providing increasing Fe levels in the diet from either FeSO4 or FeCO3 improved (P < 0.05) average daily gain, average daily feed intake, gain-to-feed ratio, and increased (P < 0.05) Hb and Hct values. A day effect (P = 0.001) was observed for both Hb and Hct with values increasing throughout the study. Increasing dietary Fe levels in the diet from either FeSO4 or FeCO3 increased (linear; P < 0.05) Hb and Hct values on days 14, 21, and 32. In summary, these data suggest that the micronized form of FeCO3 is a source of Fe that can be added to nursery diets to yield similar responses to those observed from FeSO4 supplementation. Similar to previous research, increasing dietary Fe improved the growth performance and increased Hb and Hct values when pigs have low Fe status at weaning.


Assuntos
Ração Animal/análise , Carbonatos/farmacologia , Compostos Férricos/farmacologia , Compostos Ferrosos/farmacologia , Ferro/administração & dosagem , Suínos/crescimento & desenvolvimento , Fenômenos Fisiológicos da Nutrição Animal , Animais , Peso Corporal/efeitos dos fármacos , Carbonatos/administração & dosagem , Dieta/veterinária , Feminino , Compostos Férricos/administração & dosagem , Compostos Ferrosos/administração & dosagem , Hematócrito/veterinária , Masculino , Oligoelementos
2.
Trop Anim Health Prod ; 52(3): 943-953, 2020 May.
Artigo em Inglês | MEDLINE | ID: mdl-32040659

RESUMO

This study aimed to investigate the interactive effect of dietary threonine (i.e., 100, 110, and 120%) and low and high dietary potassium (i.e., 0.85 and 0.94% of diet) on the performance, immune response, blood metabolites, carcass traits, and jejunum morphology of broiler chickens in Iran. In a completely randomized design, 300 1-day-old broiler chicks (Ross 308) were assigned to one of six dietary treatments with a 3 × 2 factorial arrangement. Broiler chicken growth performance, blood metabolite concentration, jejunum morphology, and antibody titter against Newcastle disease and influenza viruses were not affected by dietary treatments (P > 0.05). High level of dietary potassium led to lower toe web thickness index at 4 h post injection while compared to control group, threonine supplementation significantly decreased toe web thickness of broiler chickens at 24 and 48 h post injection (P < 0.05). Dietary treatments had no significant effects on carcass, abdominal fat, and breast and thigh percentages while higher dietary potassium increased serum glucose concentration (P < 0.05). Broilers fed diet supplemented with 20% supplemented threonine and higher potassium level had lower breast meat fat percentage while those fed diet supplemented with 20% threonine and low potassium had higher thigh meat protein percentage (P < 0.05). It can be concluded that although threonine supplementation improved toe web thickness index as cell-mediated immune response and lowered breast meat fat percentage in broiler chickens, there was no interaction between potassium with threonine in broiler chicken nutrition.


Assuntos
Ração Animal/análise , Carbonatos/administração & dosagem , Galinhas/crescimento & desenvolvimento , Dieta/veterinária , Potássio/administração & dosagem , Treonina/administração & dosagem , Fenômenos Fisiológicos da Nutrição Animal/efeitos dos fármacos , Animais , Suplementos Nutricionais , Irã (Geográfico) , Masculino
3.
Trop Anim Health Prod ; 52(2): 591-600, 2020 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-31444665

RESUMO

Potassium phosphate (K2HPO4) and potassium carbonate (K2CO3) administration by feed or water were evaluated on broiler performance, bone strength, alkaline phosphatase activity (ALP), and phosphorus digestibility under heat stress and high chloride condition. Experimental groups include control; 15 cc/kg K2HPO4; 30 cc/kg K2HPO4; 15 cc/l K2HPO4; and 3.7 g/kg K2CO3. Body weight (BW), feed and water consumption, plasma potassium, phosphorus, and calcium concentration along with plasma and digestive ALP and intestinal digesta pH were measured during the trial. Tibia ash, calcium and phosphorus content, and breaking strength were measured on days 21 and 42 and phosphorus digestibility on day 36 of age. As a result of this, study feed and water consumption was increased by supplementation of the feed or water with K2HPO4 (P ≤ 0.001). K2HPO4 increased body weight at 42 days of age (P ≤ 0.001). Tibia ash and phosphorus content was increased by K2HPO4 supplementation (P ≤ 0.004; P ≤ 0.003). K2CO3 did increased tibia ash but not changed tibia phosphorus content significantly. Tibia shear force, shear energy, extension, and length were improved by K2HPO4 administration at 42 days of age (P ≤ 0.001). Administration of either feed or water with K2HPO4 increased plasma potassium, phosphorus, and calcium concentration at 21 days of age, whereas K2CO3 reduced plasma potassium at 21 days of age (P ≤ 0.05). Plasma ALP reduced by addition of 15 cc K2HPO4 and K2CO3 to diets at 42 days of age, whereas digestive ALP was increased by inclusion of K2HPO4 and not by K2CO3. Supplementation of either feed or water with K2HPO4 increased phosphorus digestibility, whereas K2CO3 reduced phosphorus digestibility (P ≤ 0.003). Jejunum and ileum pH was reduced by K2HPO4 or by K2CO3 at 21 and 42 days of age (P ≤ 0.006; (P ≤ 0.05). Over all, results of current study revealed that K2HPO4 can be a suitable potassium salt choice instead of KCL in hot weather conditions especially when the water or diet contains high levels of chloride.


Assuntos
Ração Animal/análise , Carbonatos/administração & dosagem , Galinhas/fisiologia , Água Potável , Resposta ao Choque Térmico , Fosfatos/administração & dosagem , Compostos de Potássio/administração & dosagem , Potássio/administração & dosagem , Fenômenos Fisiológicos da Nutrição Animal , Animais , Densidade Óssea/efeitos dos fármacos , Cálcio da Dieta/administração & dosagem , Galinhas/crescimento & desenvolvimento , Galinhas/metabolismo , Dieta/veterinária , Suplementos Nutricionais , Digestão , Masculino , Fósforo , Fósforo na Dieta/administração & dosagem
4.
Stomatologiia (Mosk) ; 96(1): 40-42, 2017.
Artigo em Russo | MEDLINE | ID: mdl-28317828

RESUMO

The aim of the study was to elaborate the methodology of magnetic therapy for complex treatment of chronic periodontal disease (CPD). The study included 60 patients aged 35 to 65 years with moderate CPD divided in 2 groups. Patients in group 1 (controls) received impulse carbonate irrigation for 12 min №10, group 2 additionally received magnetic therapy for 5 min №10 in maxillary and mandibular areas. CLINICAL RESULTS: periodontal and rheological indices proved magnetic therapy to be useful tool for eradication of inflammation, periodontal tissue functional recovery and stabilization.


Assuntos
Periodontite Crônica/terapia , Magnetoterapia/métodos , Adulto , Idoso , Carbonatos/administração & dosagem , Feminino , Humanos , Magnetoterapia/instrumentação , Masculino , Mandíbula , Maxila , Pessoa de Meia-Idade , Irrigação Terapêutica , Resultado do Tratamento
5.
J Dairy Sci ; 98(5): 3247-56, 2015 May.
Artigo em Inglês | MEDLINE | ID: mdl-25747833

RESUMO

Water is a critical nutrient for dairy cows, with intake varying with environment, production, and diet. However, little work has evaluated the effects of water intake on rumen parameters. Using dietary potassium carbonate (K2CO3) as a K supplement to increase water intake, the objective of this study was to evaluate the effect of K2CO3 supplementation on water intake and on rumen parameters of lactating dairy cows. Nine ruminally cannulated, late-lactation Holstein cows (207±12d in milk) were randomly assigned to 1 of 3 treatments in a replicated 3×3 Latin square design with 18-d periods. Dietary treatments (on a dry matter basis) were no added K2CO3 (baseline dietary K levels of 1.67% dietary K), 0.75% added dietary K, and 1.5% added dietary K. Cows were offered treatment diets for a 14-d adaption period followed by a 4-d collection period. Ruminal total, liquid, and dry matter digesta weights were determined by total rumen evacuations conducted 2h after feeding on d 4 of the collection period. Rumen fluid samples were collected to determine pH, volatile fatty acids, and NH3 concentrations, and Co-EDTA was used to determine fractional liquid passage rate. Milk samples were collected twice daily during the collection period. Milk, milk fat, and protein yields showed quadratic responses with greatest yields for the 0.75% added dietary K treatment. Dry matter intake showed a quadratic response with 21.8kg/d for the 0.75% added dietary K treatment and 20.4 and 20.5kg/d for control and the 1.5% added dietary K treatment, respectively. Water intake increased linearly with increasing K2CO3 supplementation (102.4, 118.4, and 129.3L/d) as did ruminal fractional liquid passage rate in the earlier hours after feeding (0.118, 0.135, and 0.141 per hour). Total and wet weights of rumen contents declined linearly and dry weight tended to decline linearly as dietary K2CO3 increased, suggesting that the increasing water intake and fractional liquid passage rate with increasing K2CO3 increased the overall ruminal turnover rate. Ruminal ammonia concentrations declined linearly and pH increased linearly as K supplementation increased. As a molar percentage of total volatile fatty acids, acetate increased linearly as dietary K increased, though propionate declined. Increasing dietary K2CO3 and total K in the diets of lactating dairy cows increased water consumption and modified ruminal measures in ways suggesting that both liquid and total ruminal turnover were increased as both water and K intake increased.


Assuntos
Carbonatos/administração & dosagem , Bovinos/fisiologia , Água Potável , Ingestão de Líquidos , Potássio/administração & dosagem , Rúmen/metabolismo , Amônia/análise , Ração Animal/análise , Fenômenos Fisiológicos da Nutrição Animal , Animais , Carbonatos/análise , Dieta/veterinária , Suplementos Nutricionais , Ácidos Graxos Voláteis/análise , Feminino , Concentração de Íons de Hidrogênio , Lactação , Leite/química , Potássio/análise
6.
J Dairy Sci ; 98(3): 1950-60, 2015 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-25557895

RESUMO

Feed costs currently account for 55% or more of the total cost of milk production in US dairy herds, and dairy producers are looking for strategies to improve feed efficiency [FE; 3.5% fat-corrected milk (FCM) per dry matter (DM) intake]. Increasing dietary cation-anion difference [DCAD; Na+K-Cl (mEq/kg of DM)] has been shown to increase milk production, FCM, and FE. However, the optimal DCAD concentration for maximal FE has yet to be determined. The objectives of this research were to test the effects of DCAD concentration and cation source on dairy FE. Sixty Holstein dairy cows (20 cows per experiment) were used in three 4×4 Latin square design experiments with 3-wk experimental periods. In experiments 1 and 2, we tested the effect of DCAD concentration: cows were fed a basal diet containing ~250 mEq/kg of DM DCAD that was supplemented with potassium carbonate at 0, 50, 100, and 150 mEq/kg of DM or 0, 125, 250, and 375 mEq/kg of DM in experiments 1 and 2, respectively. In experiment 3, we tested the effect of cation source: sodium sesquicarbonate replaced 0, 33, 67, and 100% of the supplemental potassium carbonate (150 mEq/kg of DM DCAD). The DCAD concentration had no effect on milk production, milk protein concentration, or milk protein yield in experiments 1 and 2. Dry matter intake was not affected by DCAD concentration in experiment 1 or by cation source in experiment 3. However, DMI increased linearly with increasing DCAD in experiment 2. We detected a linear increase in milk fat concentration and yield with increasing DCAD in experiments 1 and 2 and by substituting sodium sesquicarbonate for potassium carbonate in experiment 3. Increased milk fat concentration with increasing DCAD led to increases in 3.5% FCM in experiments 1 and 2. Maximal dairy FE was achieved at a DCAD concentration of 426 mEq/kg of DM in experiments 1 and 2 and by substituting Na for K in experiment 3. The results of these experiments suggest that both DCAD concentration and the cation source used to alter DCAD concentration have effects on milk fat content and yield and dairy FE.


Assuntos
Cátions/metabolismo , Bovinos/fisiologia , Dieta/veterinária , Suplementos Nutricionais , Metabolismo Energético/fisiologia , Lactação/fisiologia , Leite/metabolismo , Ração Animal/análise , Animais , Bicarbonatos/administração & dosagem , Bicarbonatos/metabolismo , Carbonatos/administração & dosagem , Carbonatos/metabolismo , Suplementos Nutricionais/análise , Relação Dose-Resposta a Droga , Feminino , Leite/química , Potássio/administração & dosagem , Potássio/metabolismo , Potássio na Dieta/administração & dosagem , Potássio na Dieta/metabolismo , Sódio na Dieta/administração & dosagem , Sódio na Dieta/metabolismo
7.
Tidsskr Nor Laegeforen ; 134(19): 1855-7, 2014 Oct 14.
Artigo em Norueguês | MEDLINE | ID: mdl-25314987

RESUMO

A female in her forties with advanced incurable rectal cancer presented to our emergency department after loss of consciousness followed by brief myoclonic jerks in her legs. A cerebral MRI was normal. Her electrocardiogram showed a prolonged QTc interval of 596 milliseconds and hypokalemia was present. She had no family history of congenital long QT syndrome or of cardiovascular disease. She was not on any medication apart from having ingested 100 g caesium carbonate over the previous 11 days as an alternative cancer treatment. Caesium chloride is postulated to increase pH and thereby induce apoptosis in cancer cells. In treatment doses caesium competes with potassium for membrane transport proteins in the cardiac cell membrane and in the reabsorption tubuli of the kidneys. A result is hypokalemia shortly after depolarization during the cardiomyocytes' repolarisation phase or delayed post-depolarisation. Torsade de pointes ventricular arrhythmias, ventricular tachycardia, pump failure and death can follow. A few case reports of adverse effects from caesium ingestion have been published, as well as reports on how caesium is used in animal models to induce ventricular tachycardia, but the hazards of caesium ingestion and its long half-life are not well known in the medical care profession or among patients. As this patient's QTc interval normalised slowly to 413 milliseconds 60 days after stopping caesium ingestion, we consider caesium intoxication and convulsive syncope from a self-terminating ventricular tachycardia as the most probable aetiology. The main message from this case is that alternative medicine can have life-threatening side effects.


Assuntos
Arritmias Cardíacas/induzido quimicamente , Carbonatos/efeitos adversos , Césio/efeitos adversos , Hipopotassemia/induzido quimicamente , Síndrome do QT Longo/induzido quimicamente , Neoplasias Retais/tratamento farmacológico , Adulto , Arritmias Cardíacas/tratamento farmacológico , Carbonatos/administração & dosagem , Carbonatos/uso terapêutico , Césio/administração & dosagem , Césio/uso terapêutico , Terapias Complementares/efeitos adversos , Eletrocardiografia , Feminino , Humanos , Hipopotassemia/tratamento farmacológico , Síndrome do QT Longo/tratamento farmacológico , Pessoa de Meia-Idade , Mioclonia/induzido quimicamente , Síncope/induzido quimicamente
8.
J Sci Food Agric ; 94(8): 1628-38, 2014 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-24301903

RESUMO

BACKGROUND: Coastal countries that suffer from a scarcity of water, such as Tunisia, have to cultivate marine microalgae on non-arable land in order to produce feedstock and overcome their demands of nutrition and energy. In this framework, a green microalga, CTM 20019, was isolated, identified as Picochlorum sp. and tested for its lipid production. RESULTS: The dry weight of Picochlorum sp. is composed of 163 g kg(-1) lipids, 225 g kg(-1) total sugars, 440 g kg(-1) proteins and 112 g kg(-1) ash rich in potassium, calcium, iron, magnesium and zinc. Gas chromatography-mass spectrometry analysis showed that the main fatty acids were palmitic acid (29%), linolenic acid (26.5%), linoleic acid (23.5%), hexadecatrienoic acid (11%) and hexadecadienoic acid (8.5%). As it is known that culture conditions greatly influence the composition of microalgae, the experiments were designed to optimise the composition of the medium in order to increase Picochlorum sp. growth from OD680nm = 0.53 to OD680nm = 2.2 and lipid accumulation from 163 g kg(-1) to 190 g kg(-1) . The highest lipid contents of 570 and 585 g kg(-1) were achieved under phosphate starvation and sodium carbonate supplementation, respectively. Under these conditions, the fatty acid profile is dominated by mono-unsaturated and polyunsaturated acids, and is therefore suitable for aqua-culture feeding. However, under high salinity, growth and lipid synthesis are inhibited, and the fatty acids are saturate, and the product is therefore suitable for biodiesel. CONCLUSION: This high lipid content rich in essential fatty acids, omega-6 and omega-3, endorses this wild strain of Picochlorum sp. as a promising feedstock for aqua-culture and human nutrition or for the production of biodiesel. © 2013 Society of Chemical Industry.


Assuntos
Clorófitas/crescimento & desenvolvimento , Meios de Cultura , Lipídeos/biossíntese , Estresse Fisiológico , Ração Animal , Animais , Aquicultura/métodos , Carbonatos/administração & dosagem , Clorófitas/química , Clorófitas/classificação , Ácidos Graxos/análise , Humanos , Lipídeos/análise , Valor Nutritivo , Fosfatos/administração & dosagem , Salinidade , Tunísia
9.
Nutrition ; 30(1): 96-106, 2014 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-24290605

RESUMO

OBJECTIVES: Copper (Cu) is widely used in industry for the manufacture of a vast range of goods including Cu-intrauterine devices (IUDs), electronic products, agrochemicals, and many others. It is also one of the trace elements essential to human health in the right measure and is used as a parenteral supplement in patients unable to ingest food. Elevated Cu levels have been found in the plasma of women using Cu-IUDs and in farmers working with Cu-based pesticides. However, possible alterations due to Cu overload in the brain have been poorly studied. Therefore, the aim of this study was to investigate the effects of Cu administration on rat brain in Cu-sufficient and Cu-deficient animals fed on semi-synthetic diets with different doses of Cu (7 or 35 ppm). METHODS: We aimed to investigate the effects of Cu administration using two routes of administration: oral and intraperitoneal (IP). Male Wistar rats were feeding (one month) a complete (7 ppm) or a deficient (traces) Cu diets subdivided into three categories oral-, intraperitoneal- (or both) supplemented with copper carbonate (7 to 35 ppm). Cu content in plasma, brain zones (cortex and hippocampus), antioxidant enzyme activities, and protease systems involved in programmed cell death were determined. RESULTS: The results show that Cu levels and the concentration of Cu in plasma and brain were dose-dependent and administration route-dependent and demonstrated a prooxidative effect in plasma and brain homogenates. Oxidative stress biomarkers and antioxidative enzyme activity both increased under Cu overload, these effects being more noticeable when Cu was administered IP. Concomitantly, brain lipids from cortex and hippocampus were strongly modified, reflecting Cu-induced prooxidative damage. A significant increase in the activities of calpain (milli- and micro-) and caspase-3 activity also was observed as a function of dose and administration route. CONCLUSION: The findings of this study could be important in evaluating the role of Cu in brain metabolism and neuronal survival.


Assuntos
Encéfalo/efeitos dos fármacos , Carbonatos/efeitos adversos , Carbonatos/sangue , Cobre/efeitos adversos , Cobre/sangue , Administração Oral , Animais , Biomarcadores/sangue , Encéfalo/metabolismo , Carbonatos/administração & dosagem , Caspase 3/genética , Caspase 3/metabolismo , Cobre/administração & dosagem , Relação Dose-Resposta a Droga , Injeções Intraperitoneais , Metabolismo dos Lipídeos/efeitos dos fármacos , Masculino , Estresse Oxidativo/efeitos dos fármacos , Ratos , Ratos Wistar , Espécies Reativas de Oxigênio
10.
Clin Exp Immunol ; 167(2): 179-87, 2012 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-22235993

RESUMO

Carbon monoxide (CO) is produced during the catabolism of free haem, catalyzed by haem oxygenase (HO) enzymes, and its physiological roles include vasodilation, neurotransmission, inhibition of platelet aggregation and anti-proliferative effects on smooth muscle. In vivo preclinical studies have shown that exogenously administered quantities of CO may represent an effective treatment for conditions characterized by a dysregulated immune response. The carbon monoxide-releasing molecules (CORMs) represent a group of compounds capable of carrying and liberating controlled quantities of CO in the cellular systems. This review covers the physiological and anti-inflammatory properties of the HO/CO pathway in the central nervous system. It also discusses the effects of CORMs in preclinical models of inflammation. The accumulating data discussed herein support the possibility that CORMs may represent a novel class of drugs with disease-modifying properties in multiple sclerosis.


Assuntos
Boranos/uso terapêutico , Monóxido de Carbono/uso terapêutico , Carbonatos/uso terapêutico , Esclerose Múltipla/tratamento farmacológico , Compostos Organometálicos/uso terapêutico , Animais , Anti-Inflamatórios/administração & dosagem , Anti-Inflamatórios/uso terapêutico , Autoimunidade/efeitos dos fármacos , Boranos/administração & dosagem , Monóxido de Carbono/administração & dosagem , Monóxido de Carbono/metabolismo , Carbonatos/administração & dosagem , Cardiotônicos/administração & dosagem , Cardiotônicos/uso terapêutico , Citocinas/biossíntese , Avaliação Pré-Clínica de Medicamentos , Encefalomielite Autoimune Experimental/tratamento farmacológico , Encefalomielite Autoimune Experimental/imunologia , Guanilato Ciclase/metabolismo , Heme/metabolismo , Heme Oxigenase (Desciclizante)/fisiologia , Heme Oxigenase-1/deficiência , Heme Oxigenase-1/fisiologia , Humanos , Inflamação/tratamento farmacológico , Esclerose Múltipla/imunologia , Neuroimunomodulação/efeitos dos fármacos , Neuroimunomodulação/fisiologia , Compostos Organometálicos/administração & dosagem , Oxirredução , Receptores Citoplasmáticos e Nucleares/metabolismo , Transdução de Sinais/efeitos dos fármacos , Guanilil Ciclase Solúvel , Vasodilatadores/administração & dosagem , Vasodilatadores/uso terapêutico
11.
Toxicol Ind Health ; 27(6): 537-45, 2011 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-21511895

RESUMO

The presented study investigates the protective role of zinc (Zn) and selenium (Se) in attenuating benzene-induced toxicity in rats. Male Sprague-Dawley rats were injected with benzene (0.5 mL/kg body weight ip) and received a diet supplement containing Zn and Se. Several hematological and biochemical parameters (representing antioxidant status) were estimated. Histopathological examinations were performed. Results showed that food intake and body weight gain of benzene-injected rats were significantly lower than that of the control rats. Benzene-injected rats showed increased plasma malondialdehyde (MDA) and decreased activity of: glutathione peroxidase (GSH-Px), catalase, superoxide dismutase (SOD) enzymes, as well as reduced glutathione (GSH) when compared to the control group. Histopathological investigations revealed structural changes in benzene-injected rats' liver. Supplementation with Zn and Se resulted in a significant decrease in MDA, elevation in GSH, GSH-Px, SOD and catalase levels. This study shows that Zn and Se supplementation can improve the activity of antioxidant enzymes in rats and decrease the histological anomalies induced by benzene toxicity as well.


Assuntos
Antioxidantes/administração & dosagem , Benzeno/toxicidade , Carbonatos/administração & dosagem , Doenças Hematológicas/prevenção & controle , Compostos de Selênio/administração & dosagem , Compostos de Zinco/administração & dosagem , Ração Animal , Animais , Suplementos Nutricionais , Ingestão de Alimentos/efeitos dos fármacos , Doenças Hematológicas/induzido quimicamente , Doenças Hematológicas/patologia , Rim/efeitos dos fármacos , Rim/patologia , Fígado/efeitos dos fármacos , Fígado/patologia , Masculino , Tamanho do Órgão/efeitos dos fármacos , Estresse Oxidativo/efeitos dos fármacos , Ratos , Ratos Sprague-Dawley , Ácido Selênico , Baço/efeitos dos fármacos , Baço/patologia , Aumento de Peso/efeitos dos fármacos
12.
Minerva Endocrinol ; 33(1): 7-13, 2008 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-18277375

RESUMO

AIM: The aim of this study was to test the possibility of enhancing blood calcium levels in totally thyroidectomized patients by supplementation with 1 L/d carbonate-bicarbonate-high-calcium mineral water. METHODS: This study enrolled 95 outpatients, totally thyroidectomized four months earlier, and hence treated with oral calcium and vitamin-D. At recruitment, ionized blood calcium was either below (Group A; N. 55) or above (Group B; N. 40, randomly divided in Group B1 [N. 20] and Group B2 [N.20]) the lower limit of the normal range (1.12 mmol/L). For one month, Group A was treated with 1 L/d high-calcium (483 mg/L) mineral water and continued the usual therapy with Ca and vitamin-D. In contrast, Group B1 and Group B2 substituted their Ca and vitamin-D therapy with 1 L/d high-calcium mineral water (Group B1) or 1 L/d of placebo mineral water (Ca:80 mg/L) (Group B2). RESULTS: After one month, a significant 7.5% increase in blood ionized-calcium levels was observed in Group A, no change in Group B1 and a significant drop below normality in Group B2 (Group B2 vs Group B1, P<0.001). Thereafter, 1 L/d of the high-calcium mineral water, given to Group B2 instead of placebo for an additional month, significantly enhanced ionized-calcium levels above the lower limit of normality (Group B2 vs Group B1, NS). CONCLUSION: These experiments show that calcium supplementation as 1 L/d of a high-calcium mineral water may efficaciously enhance blood calcium levels in thyroidectomized patients. This complementary treatment might at least in part contribute to the prevention and/or treatment of hypocalcemia and substitute vitamin-D and calcium therapies after thyroidectomy.


Assuntos
Cálcio/uso terapêutico , Hipocalcemia/tratamento farmacológico , Águas Minerais/uso terapêutico , Tireoidectomia/efeitos adversos , Adulto , Calcitriol/administração & dosagem , Calcitriol/uso terapêutico , Cálcio/administração & dosagem , Cálcio/sangue , Compostos de Cálcio/administração & dosagem , Compostos de Cálcio/uso terapêutico , Carbonatos/administração & dosagem , Carbonatos/uso terapêutico , Estudos Cross-Over , Relação Dose-Resposta a Droga , Feminino , Bócio/cirurgia , Humanos , Hipocalcemia/sangue , Hipocalcemia/etiologia , Hipoparatireoidismo/sangue , Hipoparatireoidismo/etiologia , Lactatos/administração & dosagem , Lactatos/uso terapêutico , Masculino , Águas Minerais/análise , Hormônio Paratireóideo/sangue , Hormônios Tireóideos/sangue , Tireotropina/sangue , Tiroxina/uso terapêutico
13.
Aging Clin Exp Res ; 14(1): 13-7, 2002 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-12027147

RESUMO

BACKGROUND AND AIMS: Supplementation of postmenopausal women with calcium alone or calcium-vitamin D association was suggested to have positive effects on bone turnover and bone density, as well as to lower fracture incidence. The beneficial effect appears to be mediated by a reduction in parathyroid hormone secretion. Our aim was to compare the respective efficacy of calcium and calcium-vitamin D supplements in reducing serum parathyroid hormone levels in postmenopausal women with prevalent low 25(OH)vitamin D levels. METHODS: One hundred consecutive ambulatory postmenopausal women with serum 25(OH)vitamin D levels below 18 ng/mL were included in a randomized, prospective, open label study. For a duration of 90 days, the women were randomly assigned to a daily supplementation of either one tablet of calcium gluconolactate and carbonate (500 mg calcium), or one powder-pack of an association of calcium carbonate (500 mg calcium), citric acid (2.175 gr) and cholecalciferol (200 IU). Changes observed during the 90 days of the study in circulating PTH levels were the primary endpoint, while changes in serum 25(OH)D levels were assessed as secondary endpoint. RESULTS: A significant difference was observed between the calcium-vitamin D (CaD) and the calcium (Ca) only groups for changes occurring during the 90 days of the study in PTH (-14.5+/-40% and +2.5+/-46%) (p=0.009) and 25(OH)D (+67+/-77% and +18+/-55%) (p<0.001) circulating levels. PTH changes between baseline and day 90 were significant in the CaD group, but not in the Ca group. The odds ratio for a patient in group Ca to experience an absolute (<12 ng/mL) deficiency in circulating 25(OH)vitamin D levels, compared to a group CaD patient was statistically increased (OR: 3.22, 95% CI: 1.33-7.80). CONCLUSIONS: Our results support the recommendation of supplementing postmenopausal women with low circulating levels of 25(OH)vitamin D with a combination of calcium and vitamin D, rather than with calcium alone.


Assuntos
Compostos de Cálcio/administração & dosagem , Carbonatos/administração & dosagem , Hiperparatireoidismo Secundário/prevenção & controle , Lactatos/administração & dosagem , Deficiência de Vitamina D/tratamento farmacológico , Vitamina D/análogos & derivados , Vitamina D/administração & dosagem , Vitamina D/sangue , Idoso , Carbonato de Cálcio/administração & dosagem , Combinação de Medicamentos , Feminino , Seguimentos , Humanos , Pessoa de Meia-Idade , Pós-Menopausa , Estudos Prospectivos
14.
Acta Odontol Scand ; 58(1): 1-7, 2000 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-10809392

RESUMO

A cross-sectional study of 143 children aged 10-14 years was carried out to identify factors associated with the severity of dental fluorosis in 2 areas (Moshi/Kibosho: n = 63/80) with fluoride (F) concentrations < 0.4 mg F/L in the drinking water. Dental fluorosis was recorded under field conditions using the Thylstrup and Fejerskov index (TFI). The score on tooth 21 was used to indicate the severity. The prevalence of dental fluorosis in Moshi at TFI score > or =1 was 60% and at TFI score > or =5 it was 10%. The corresponding values in Kibosho were 100% and 34%, respectively. Background variables pertained primarily to the child's first 6 years of life. In Moshi and Kibosho, 65% and 97% of children, respectively, used magadi, a fluoride-containing food tenderizer. In Moshi, the risk of having TFI score > or =2 was significantly higher among users of magadi (odds ratio (OR) = 5). Kiborou, a traditional homemade weaning food (porridge) cooked with magadi, was used only in Kibosho. Users of kiborou (36%) were at significantly higher risk (OR = 3) of developing fluorosis at severity TFI > or =4 than the users of lishe, another type of weaning food. All children in Moshi and 64% in Kibosho used lishe, which is cooked without magadi. Magadi and kiborou were significant risk indicators. Thus, it seems that the unexpectedly high prevalence of dental fluorosis and the observed differences in fluorosis prevalence and severity may be partly explained by F exposure from magadi.


Assuntos
Carbonatos/administração & dosagem , Comportamento Alimentar , Fluoretos/administração & dosagem , Fluorose Dentária/etiologia , Aditivos Alimentares/administração & dosagem , Alimentos , Bicarbonato de Sódio/administração & dosagem , Desmame , Adolescente , Arachis , Distribuição de Qui-Quadrado , Criança , Estudos Transversais , Fabaceae , Feminino , Produtos Pesqueiros , Fluorose Dentária/classificação , Humanos , Masculino , Razão de Chances , Plantas Medicinais , Prevalência , Fatores de Risco , Tanzânia , Zea mays , Zingiberales
15.
Ann Emerg Med ; 35(1): 3-10, 2000 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-10613934

RESUMO

STUDY OBJECTIVE: Advanced cardiac life support (ACLS) guidelines recommend a 3- to 5-minute interval between repeated doses of epinephrine. This recommendation does not take into account the dose of epinephrine used, and only very limited data exist regarding the hemodynamic responses to repeated "high" doses of epinephrine. The objective of this study was to analyze the hemodynamic responses to repeated, equal, high doses of epinephrine administered during cardiopulmonary resuscitation (CPR) in a canine model of ventricular fibrillation (VF). METHODS: This study used a secondary analysis of data collected in a prospective, randomized study, primarily designed to assess the effects of acid buffers in a canine model of cardiac arrest. VF was electrically induced. After 10 minutes, CPR was initiated, including ventilation with FIO(2)=1.0, external chest compressions, administration of epinephrine (0.1 mg/kg repeated every 5 minutes) and defibrillation. Animals were randomized to receive either NaHCO(3), Carbicarb, tromethamine (THAM), or NaCl. The hemodynamic variables were sampled from each experiment's paper chart at 1-minute intervals, and the responses to the first 4 doses of epinephrine were compared. RESULTS: Thirty-six animals (9 in each buffer group) were included in this analysis. Systolic, diastolic, and coronary perfusion pressures increased steeply (by 100%, 130%, and 190%, respectively) only after the first epinephrine dose. These pressures peaked at 2 to 3 minutes and decreased only slightly and insignificantly during the rest of the 5-minute interval, until the next epinephrine dose. No further significant increases in arterial pressures were observed in response to the next 3 doses of epinephrine, administered 5 minutes apart. CONCLUSION: The hemodynamic effects of high-dose epinephrine (0.1 mg/kg) during CPR appear to last longer than 5 minutes. Therefore, longer intervals between doses may be justified with high doses of epinephrine.


Assuntos
Agonistas alfa-Adrenérgicos/administração & dosagem , Pressão Sanguínea/efeitos dos fármacos , Reanimação Cardiopulmonar/métodos , Epinefrina/administração & dosagem , Vasoconstritores/administração & dosagem , Fibrilação Ventricular/tratamento farmacológico , Fibrilação Ventricular/fisiopatologia , Agonistas alfa-Adrenérgicos/farmacologia , Animais , Soluções Tampão , Carbonatos/administração & dosagem , Carbonatos/farmacologia , Modelos Animais de Doenças , Cães , Esquema de Medicação , Combinação de Medicamentos , Avaliação Pré-Clínica de Medicamentos , Quimioterapia Combinada , Epinefrina/farmacologia , Guias de Prática Clínica como Assunto , Distribuição Aleatória , Bicarbonato de Sódio/administração & dosagem , Bicarbonato de Sódio/farmacologia , Cloreto de Sódio/administração & dosagem , Cloreto de Sódio/farmacologia , Fatores de Tempo , Trometamina/administração & dosagem , Trometamina/farmacologia , Vasoconstritores/farmacologia
17.
J Toxicol Environ Health A ; 53(3): 211-22, 1998 Feb 06.
Artigo em Inglês | MEDLINE | ID: mdl-9482352

RESUMO

The developmental toxicity potential of a scrubbing solution used extensively in petroleum refineries to remove CO2 from hydrogen gas streams was evaluated via inhalation. Pregnant female CD (Sprague-Dawley) rats were exposed to aerosols of a "used" scrubbing solution at 0.05, 0.1, 0.2, or 0.3 mg/l for 6 h/d on d 6-19 of pregnancy. Control animals were exposed to filtered air under the same exposure conditions. Dams were sacrificed on d 20 of pregnancy and a laparohysterectomy was performed. The mass median aerodynamic diameter of the aerosol revealed that all particles ranged from 1.6 to 2.8 microm, with geometric standard deviations between 2.0 and 2.3 microm. The overall pregnancy rate was high (>95%) and equivalent across all groups. All pregnant dams had live litters, and 22-24 litters were examined in each group. Treatment-related clinical signs consisted of rales, observed at all exposure levels, and gasping noted only at the 0.3 mg/l exposure level. The occurrence of rales was presumably a localized effect on the respiratory tract and likely due to the irritating properties of the scrubbing solution. Maternal toxicity was exhibited in the 0.3 mg/l group, including reduced body weight, weight gain, and food consumption and one possible treatment-related death on gestation d 17. At scheduled necropsy, there were no treatment-related gross pathological observations and no statistically significant reproductive and developmental effects. The incidences of fetuses with skeletal variations involving the sternum were clustered in two litters at the highest exposure level with atypically low term fetal body weights. Under the conditions of this investigation, potassium carbonate scrubbing solution is not a selective developmental toxicant.


Assuntos
Carbonatos/toxicidade , Desenvolvimento Embrionário e Fetal/efeitos dos fármacos , Potássio/toxicidade , Sabões/toxicidade , Acidentes de Trabalho , Administração por Inalação , Aerossóis , Animais , Câmaras de Exposição Atmosférica , Blastocisto/efeitos dos fármacos , Peso Corporal/efeitos dos fármacos , Carbonatos/administração & dosagem , Relação Dose-Resposta a Droga , Ingestão de Alimentos/efeitos dos fármacos , Feminino , Tamanho da Ninhada de Vivíparos/efeitos dos fármacos , Petróleo , Potássio/administração & dosagem , Gravidez , Complicações na Gravidez/induzido quimicamente , Ratos , Ratos Sprague-Dawley , Sons Respiratórios/etiologia , Esterno/anormalidades , Aumento de Peso/efeitos dos fármacos
19.
Artigo em Russo | MEDLINE | ID: mdl-8686219

RESUMO

Experimental alimentary obesity was treated with hydrocarbonate magnesium-calcium water from Shmakovskoe deposit and hydrocarbonate-chloride sodium arsenous boric iodine-bromine water from springs in Sinegorsk. The study of lipid and carbohydrate metabolism proved the ability of the waters to prevent complex metabolic disorders typical for obesity.


Assuntos
Metabolismo dos Carboidratos , Carbonatos/administração & dosagem , Lipídeos/sangue , Águas Minerais/administração & dosagem , Obesidade/terapia , Administração Oral , Animais , Carbonatos/análise , Avaliação Pré-Clínica de Medicamentos , Fígado/metabolismo , Masculino , Águas Minerais/análise , Obesidade/metabolismo , Ratos , Ratos Wistar , Sibéria
20.
J Trace Elem Med Biol ; 9(2): 102-11, 1995 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-8825983

RESUMO

Seven pairs of purebred Landrace first-litter gilts, housed in individual stainless-steel metabolic cages were used in this study. A low-Cu (LCu) basal diet containing only 2 mg/kg of Cu was compared to the control (CCu) diet, which was supplemented with cupric carbonate to provide 10 mg/kg of Cu. Both diets were fed at the rate of 2 kg per day to first-litter gilts during the entire pregnancy. The metabolic response under these two levels of dietary Cu intake was evaluated through nutritional balances conducted for 5 days starting at 30, 60 and 100 days of pregnancy. Total urine collection was done through teflon-coated catheters to the bladder while daily fecal collection was carried out continuously. Water consumption was measured and periodic samples were collected for analysis. Nutritional balances included DM digestibility, Cu, Zn, Fe and Mn. The LCh group consumed 4.26 mg of Cu per day while the CCu received 25 mg of Cu per day. This includes 1 mg per day in the drinking water in both groups. DM digestibility was significantly (P < 0.05) higher during early pregnancy in the LCu group compared to the CCu group, which showed a significant (P < 0.05) increase in DM digestibility from early to late pregnancy period. Dietary Cu intake had a direct effect (p < 0.05) on Cu balance but also altered the Zn and Fe nutritional balance, leaving Mn balance almost unchanged. Feces represented the almost exclusive route of excretion of trace minerals. Regardless of the dietary Cu intake, it represents more than 99.9% of the Fe and Mn, 98% of the Zn and 97% of the Cu was excreted daily through feces plus urine. The nutritional balance of Cu, Zn and Fe, in absolute amounts as well as relative to the level of intake, improved significantly as pregnancy progressed. Although relative retention of the low-Cu group was significantly improved compared to the control group, the absolute amount was still much lower. The well recognized dietary and metabolic interactions of Cu with Zn and Fe were evident in the first-litter gilts receiving the low-Cu diet during pregnancy. The absolute amount, as well as the relative retention as a % of the intake, was increased on average during the entire pregnancy for Zn by more than 70% and for Fe by more than 80% during the last third of pregnancy. In contrast Mn balance was almost unchanged. The major response to low-Cu intake was directed toward greater apparent absorption of the trace minerals which was reflected in a reduced fecal excretion.


Assuntos
Cobre/metabolismo , Alimentos Fortificados , Suínos/metabolismo , Oligoelementos/metabolismo , Animais , Carbonatos/administração & dosagem , Cobre/administração & dosagem , Cobre/urina , Dieta , Ingestão de Líquidos , Ingestão de Alimentos , Fezes/química , Feminino , Ferro/metabolismo , Ferro/urina , Manganês/metabolismo , Manganês/urina , Estado Nutricional , Gravidez , Zinco/metabolismo , Zinco/urina
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA